Abstract
Magnetic resonance methods currently in use for the assessment of human subjects include magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and functional magnetic resonance imaging (fMRI). MRI provides detailed information regarding brain anatomy, with spatial resolution on the order of 1 mm3, and is widely used to characterize neuropathological conditions in clinical practice. MRS allows the detection of signals from certain drugs and from a limited number of endogenous neurochemicals, with spatial resolution on the order of 1 cm3, depending upon the compound under investigation. fMRI refers to a family of methods for obtaining brain images which are sensitive to changes in cerebral metabolism with spatial resolution on the order of a few millimeters and temporal resolution of a few seconds. MRI, MRS, and fMRI rely on the same basic principles and, at least for human studies, generally use the same hardware. Although the technology is evolving rapidly, there are currently more than 1000 installed 1.5 Tesla (T) MR scanners in the United States which are capable of performing some or all of these methodologies. Thus, this technology is widely disseminated and available to investigators at a number of clinical research sites. This review will describe the basic principles of MRI, MRS, and fMRI. With this information as background, the literature on the use of MR in substance abuse research is reviewed in Chapter 6.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ackerman, J. J. H., Grove, T. H., Wong, G. G., Gadian, D. G. and Radda, G. K., Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature 283: 167–170, 1980.
Alger, J. R., Behar, K. L., Rothman, D. L. and Shulman, R. G., Natural-abundance 13C NMR measurement of hepatic glycogen in the living rabbit. J. Magn. Reson. 56: 334–337, 1984.
Andreasen, N. C., Ehrhardt, J. C., Swayze, V. W., 2nd., Tyrrell, G., Cohen, G., Ku, J. S. and Arndt, S., Ti and T2 relaxation times in schizophrenia as measured with magnetic resonance imaging. Schizophrenia Res. 5: 223–232, 1991.
Arnold, J. T., Dharmatti, S. S. and Packard, M. E., Chemical effects on nuclear induction signals from organic compounds. J. Chem. Phys. 19: 507, 1951.
Aronen, H. J., Glass, J., Pardo, F. S., Belliveau, J. W., Gruber, M. L., Buchbinder, B. R., Gazit, I. E., Linggood, R. M., Fischman, A., Rosen, B. R. and Hochberg, F. H., Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol. 36: 520–528, 1995.
Balschi, J. A., Cirillo, V. P. and Springer, C. S. J., Direct high-resolution nuclear magnetic resonance studies of cation transport in vivo, Na+ transport in yeast cells. Biophys. J. 38: 323–326, 1982.
Bandettini, P. A., Jesmanowicz, A., Wong, E. C. and Hyde, J. S., Processing strategies for time-course data sets in functional MRI of the human brain. Magn. Reson. Med. 30: 161–173, 1993.
Barker, P. B., Breiter, S. N., Soher, B. J., Chatham, J. C., Forder, J. R., Samphilipo, M. A., Magee, C. A. and Anderson, J. H., Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn. Reson. Med. 32: 157–163, 1994.
Belliveau, J. W., Rosen, B. R., Kantor, H. L., Rzedzian, R. R., Kennedy, D. N., McKinstry, R. C., Vevea, J. M., Cohen, M. S., Pykett, I. L. and Brady, T. J., Functional cerebral imaging by susceptibility-contrast NMR. Magn. Reson. Med. 14: 538–546, 1990.
Belliveau, J. W., Kennedy, D. N. J., McKinstry, R. C., Buchbinder, B. R., Weisskoff, R. M., Cohen, M. S., Vevea, J. M., Brady, T. J. and Rosen, B. R., Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254: 716–719, 1991.
Birken, D. L. and Oldendorf, W. H., N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci. Biobehay. Rev. 13: 23–31, 1989.
Biswal, B., DeYoe, A. E. and Hyde, J. S., Reduction of physiological fluctuations in fMRI using digital filters. Magn. Reson. Med. 35: 107–113, 1996.
Bloch, F., Hansen, W. W. and Packard, M., Nuclear induction. Phys. Rev. 69: 127, 1946.
Boada, F. E., Gillen, J. S., Shen, G. X., Chang, S. Y. and Thulborn, K. R., Fast three dimensional sodium imaging. Magn. Reson. Med. 37: 706–715, 1997.
Bottomley, P. A., Foster, T. B. and Darrow, R. D., Depth-resolved surface coil spectroscopy (DRESS) for in vivo 1H, 31P and 13C NMR. J. Magn. Reson. 59: 338–343, 1984.
Bracewell, R. N., The Fourier Transform and Its Applications. Singapore, McGraw-Hill Book Company, 1986.
Bradley, W. G. J., Yuh, W. T. and Bydder, G. M., Use of MR imaging contrast agents in the brain. J. Magn. Reson. Imaging 3: 199–218, 1993.
Breiter, H. C., Gollub, R. L., Weisskoff, R. M., Kennedy, D. N., Makris, N., Berke, J. D., Goodman, J. M., Kantor, H. L., Gastfriend, D. R., Riorden, J. P., Mathew, R. T., Rosen, B. R. and Hyman, S. E., Acute effects of cocaine on human brain activity and emotion. Neuron 19: 591–611, 1997.
Brown, T. R., Kincaid, B. M. and Ugurbil, K., NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA 79: 3523–3526, 1982.
Buchli, R., Duc, C. O., Martin, E. and Boesiger, P., Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter. Magn. Reson. Med. 32: 447–452, 1994.
Bullmore, E., Brammer, M., Williams, S. C., Rabe-Hesketh, S., Janot, N., David, A., Mellers, J., Howard, R. and Sham, P., Statistical methods of estimation and inference for functional MR image analysis. Magn. Reson. Med. 35: 261–277, 1996.
Buonocore, M. H. and Maddock, R. J., Noise suppression digital filter for functional magnetic resonance imaging based on image reference data. Magn. Reson. Med. 38: 56–69, 1997.
Christensen, J. D., Babb, S. M., Cohen, B. M. and Renshaw, R. F., Quantitation of dexfenfluramine/ d-norfenfluramine concentration in primate brain using 19F NMR spectroscopy. Magn. Reson. Med. 39: 149–154, 1998.
Christensen, J. D., Yurgelun-Todd, D. A., Babb, S. M., Gruber, S., Cohen, B. M. and Renshaw, P. F., Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy. Brain Res. 834: 1–5, 1999.
Cohen, B. M., Yurgelun-Todd, D. A., English, C. D. and Renshaw, P. F., Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI. Am. J. Psychiatry 152: 1801–1803, 1995.
Cohen, S. M., Shulman, R. G. and McLaughlin, A. C., Effects of ethanol on alanine metabolism in perfused mouse liver studied by 13C NMR. Proc. Natl. Acad. Sci. USA 76: 4808–4812, 1979.
Doddrell, D. M., Galloway, G., Brooks, W., Field, J., Bulsing, J., Irving, M. and Baddeley, H., Water signal elimination in vivo using suppression by mistimed echo and repetitive gradient episodes. J. Magn. Reson. 70: 176–180, 1986.
Eddy, W. F., Fitzgerald, M. and Noll, D. C., Improved image registration by using Fourier interpolation. Magn. Reson. Med. 36: 923–931, 1996.
Ernst, R. R. and Anderson, W. A., Application of Fourier transform spectroscopy to magnetic resonance. Rev. Sci. Inst. 37: 93–102, 1966.
Farrar, T. C., An introduction to pulse NMR spectroscopy. The Farragut Press, Madison, 1989. Fox, P. T. and Raichle, M. E., Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc. Natl. Acad. Sci. USA 83: 1140–1144, 1986.
Fox, P. T., Raichle, M. E., Mintun, M. A. and Dence, C., Nonoxidative glucose consumption during focal physiologic neural activity. Science 241: 462–464, 1988.
Frank, L. R., Buxton, R. B. and Wong, E. C., Probabilistic analysis of functional magnetic resonance imaging data. Magn. Reson. Med. 39: 132–148, 1998.
Fransson, P., Kruger, G., Merboldt, K. D. and Frahm, J., Temporal characteristics of oxygenation-sensitive MRI responses to visual activation in humans. Magn. Reson. Med. 39: 912–919, 1998.
Gering, D. T. and Weber, D. M., Intraoperative, real-time, functional MRI. J. Magn. Reson. Imaging 8: 254–257, 1998.
Gold, S., Christian, B., Arndt, S., Zeien, G., Cizadlo, T., Johnson, D. L., Flaum, M. and Andreasen, N. C., Functional MRI statistical software packages: a comparative analysis. Human Brain Mapping 6: 73–84, 1998.
Gollub, R. L., Breiter, H. C., Kantor, H., Kennedy, D., Gastfriend, D., Mathew, R. T., Makris, N., Guimaraes, A., Riorden, J., Campbell, T., Foley, M., Hyman, S. E., Rosen, B. and Weisskoff, R., Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects. J. Cereb. Blood Flow Metab. 18: 724–734, 1998.
Gonzalez, R. G., Guimaraes, A. R., Sachs, G. S., Rosenbaum, J. F., Garwood, M. and Renshaw, P. F., Measurement of human brain lithium in vivo by MR spectroscopy. AJNR Am. J. Neuroradiol. 14: 1027–1037, 1993.
Gonzalez, R. G., Fischman, A. J., Guimaraes, A. R., Carr, C. A., Stern, C. E., Halpern, E. F., Growdon, J. H. and Rosen, B. R., Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fluorodeoxyglucose [F 18]. AJNR Am. J. Neuroradiol. 16: 1763–1770, 1995.
Greenberg, S. B., Faerber, E. N., Aspinall, C. L. and Adams, R. C., High-dose chloral hydrate sedation for children undergoing MR imaging: safety and efficacy in relation to age. AJR Am J. Roentgenol. 161: 639–641, 1993.
Gupta, R. K. and Gupta, P., Direct observation of resolved resonances from intra-and extracellular sodium-23 ions in NMR studies of intact cells and tissues using dysprosium(III)tripolyphosphate as paramagnetic shift reagent. J. Magn. Reson. 47: 344–350, 1982.
Haase, A., Frahm, J., Hanicke, W. and Matthaei, D., 1H NMR chemical shift selective (CHESS) imaging. Physics Med. Biol. 30: 341–344, 1985.
Hajnal, J. V., Myers, R., Oatridge, A., Schwieso, J. E., Young, I. R. and Bydder, G. M., Artifacts due to stimulus correlated motion in functional imaging of the brain. Magn. Reson. Med. 31: 283–291, 1994.
Harris, G. J., Lewis, R. F., Satlin, A., English, C. D., Scott, T. M., Yurgelun-Todd, D. A. and Renshaw, P. F., Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer’s disease. Am. J. Psychiatry 153: 721–724, 1996.
Hoult, D. I., Busby, S. J. W., Gadian, D. G., Radda, G. K., Richards, R. E. and Seeley, P. J., Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 252: 285–287, 1974.
ladecola, C., Neurogenic control of the cerebral microcirculation: is dopamine minding the store ? Nat. Neurosci. 1: 263–265, 1998.
Jezzard, P. and Balaban, R. S., Correction for geometric distortion in echo planar images from Bo field variations. Magn. Reson. Med. 34: 65–73, 1995.
Jezzard, P. and Song, A. W., Technical foundations and pitfalls of clinical fMRI. Neuroimage 4: S63 — S75, 1996.
Kanal, E. and Shellock, F. G., The value of published data on MR compatibility of metallic implants and devices. AJNR Am. J. Neuroradiol. 15: 1394–1396, 1994.
Kaufman, M. J., Levin, J. M., Maas, L. C., Rose, S. L., Lukas, S. E., Mendelson, J. H., Cohen, B. M. and Renshaw, P. F., Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study. Psychopharmacology (Berl.) 138: 76–81, 1998.
Keltner, J. R., Wald, L. L., Christensen, J. D., Maas, L. C., Moore, C. M., Cohen, B. M. and Renshaw, P. F., A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses. Magn. Reson. Med. 36: 458–461, 1996.
Keltner, J. R., Wald, L. L., Frederick, B. de B. and Renshaw, P. F., In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn. Reson. Med. 37:366–371, 1997.
Kim, S. G., Richter, W. and Ugurbil, K., Limitations of temporal resolution in functional MRI. Magn. Reson. Med. 37: 631–636, 1997.
Klein, D. S., Prevention of claustrophobia induced by MR imaging: use of alprazolam. AJR Am. J. Roentgenol. 156: 633, 1991.
Komoroski, R. A., Newton, J. E., Karson, C., Cardwell, D. and Sprigg, J., Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy. Biol. Psychiatry 29: 711–714, 1991.
Krimer, L. S., Muly, E. C., Williams, G. V. and Goldman-Rakic, P. S., Dopaminergic regulation of cerebral cortical microcirculation. Nat. Neurosci. 1: 286–289, 1998.
Kwong, K. K., Belliveau, J. W., Chesler, D. A., Goldberg, I. E., Weisskoff, R. M., Poncelet, B. P., Kennedy, D. N., Hoppel, B. E., Cohen, M. S., Turner, R., Cheng, H.-M., Brady, T. J. and Rosen, B. R., Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. USA 89: 5675–5679, 1992.
Lauterbur, P. C., Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242: 190–191, 1973.
Le Bihan, D., Turner, R., Douek, P. and Patronas, N., Diffusion MR imaging: clinical applications. AJR Am. J. Roentgenol. 159: 591–599, 1992.
Lee, A. T., Glover, G. and Meyer, C. H., Discrimination of large venous vessels in time-course spiral blood-oxygen-level-dependent magnetic resonance functional neuroimaging. Magn. Reson. Med. 33: 745–754, 1995.
Levin, J. M., Kaufman, M. J., Ross, M. H., Mendelson, J. H., Maas, L. C., Cohen, B. M. and Renshaw, P. F., Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn. Reson. Med. 34: 655–663, 1995.
Levin, J. M., Ross, M. H., Kaufman, M. J., Lange, N., Frederick, B., von Rosenberg, H. L., Mendelson, J. H., Cohen, B. M. and Renshaw, P. F., BOLD fMRI signal depends upon baseline hemoglobin concentration. International Society for Magnetic Resonance in Medicine, Sixth Scientific Meeting and Exhibition.. Sydney, Australia, p. 13, 1998a.
Levin, J. M., Ross, M. H., Mendelson, J. H., Kaufman, M. J., Lange, N., Maas, L. C., Mello, N. K., Cohen, B. M. and Renshaw, P. F., Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res. 82: 135–146, 1998b.
Levin, J. M., Ross, M. H., Mendelson, J. H., Mello, N. K., Cohen, B. M. and Renshaw, P. F., Sex differences in blood-oxygenation-level-dependent functional MRI with primary visual stimulation. Am. J. Psychiatry 155: 434–436, 1998c.
Levin, J. M., Kaufman, M. J., Ross, M. H., Roc, A. C., Maas, L. C., Mendelson, J. H., Cohen, B. M. and Renshaw, R. F., Cocaine Increases BOLD fMRI Response to Photic Stimulation. International Society for Magnetic Resonance in Medicine, Seventh Scientific Meeting and Exhibition. Philadelphia, PA, p. 838, 1999.
Lim, K. O., Adalsteinsson, E., Spielman, D., Sullivan, E. V., Rosenbloom, M. J. and Pfefferbaum, A., Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch. Gen. Psychiatry 55: 346–352, 1998.
Lo, E. H., Matsumoto, K., Pierce, A. R., Garrido, L. and Luttinger, D., Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 14: 597–603, 1994.
Loeber, R. T., Sherwood, A. R., Renshaw, P. F., Cohen, B. M. and Yurgelun-Todd, D. A., Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophrenia Res. 37: 81–89, 1999.
Luyten, R. R., Bruntink, G., Sloff, F. M., Vermeulen, J. W. A. H., van der Heijden, J. I., den Hollander, J. A. and Heerschap, A., Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed. 1: 177–183, 1989.
Maas, L. C., Frederick, B. de B. and Renshaw, P. F., Decoupled automated rotational and translational registration for functional MRI time series data: the DART registration algorithm. Magn. Reson. Med. 37: 131–139, 1997a.
Maas, L. C., Harris, G. J., Satlin, A., English, C. D., Lewis, R. F. and Renshaw, R. F., Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer’s disease: a principal components analysis. J. Magn. Reson. Imaging 7: 215–219, 1997b.
Magin, R. L., Liburdy, R. R. and Persson, B. (eds.), Annals of the New York Academy of Science, vol. 649: Biological Effects and Safety Aspects of Nuclear Magnetic Resonance Imaging and Spectroscopy. New York Academy of Science, New York, 1992.
Mason, G. F., Behar, K. L. and Lai, J. C., The 13C isotope and nuclear magnetic resonance: unique tools for the study of brain metabolism. Metab. Brain Dis. 11: 283–313, 1996.
McCann, U., Hatzidimitriou, G., Ridenour, A., Fischer, C., Yuan, J., Katz, J. and Ricaurte, G., Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. J. Pharmacol. Exp. Ther. 269: 792–798, 1994.
McCann, U. D., Seiden, L. S., Rubin, L. J. and Ricaurte, G. A., Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. JAMA 278: 666–672, 1997.
Melendez, C. and McCrank, E., Anxiety-related reactions associated with magnetic resonance imaging examinations. JAMA 270: 745–747, 1993.
Miller, B. L., A review of chemical issues in 1H NMR spectroscopy: N-acetyl aspartate, creatine, and choline. NMR Biomed. 4: 47–54, 1991.
Moon, R. B. and Richards, J. H., Determination of intracellular pH by 31P magnetic resonance. J. Biol. Chem. 248: 7276–7278, 1973.
Moore, C. M., Breeze, J. L., Kukes, T. J., Rose, S. L., Dager, S. R., Cohen, B. M. and Renshaw, P. F., Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry 45: 1197–1202, 1999.
Murphy-Boesch, J., Stoyanova, R., Srinivasan, R., Willard, T., Vigneron, D., Nelson, S., Taylor, J. S. and Brown, T. R., Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed. 6: 173–180, 1993.
Odeblad, E. and Lindstrom, G., Some preliminary observations on the proton magnetic resonance in biologic samples. Acta Radiol. 43: 469–476, 1955.
Ogawa, S., Lee, T. M., Kay, A. R. and Tank, D. W., Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA 87: 9868–9872, 1990.
Ogawa, S., Tank, D. W., Menon, R., Ellermann, J. M., Kim, S. G., Merkle, H. and Ugurbil, K., Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc. Natl. Acad. Sci. USA 89: 5951–5955, 1992.
Ogawa, S., Menon, R. S., Kim, S. G. and Ugurbil, K., On the characteristics of functional magnetic resonance imaging of the brain. Ann. Rev. Biophys. Biomolec. Structure 27: 447–474, 1998.
Ojemann, J. G., Buckner, R. L., Akbudak, E., Snyder, A. Z., Ollinger, J. M., McKinstry, R. C., Rosen, B. R., Petersen, S. E., Raichle, M. E. and Conturo, T. E., Functional MRI studies of word-stem completion: reliability across laboratories and comparison to blood flow imaging with PET. Human Brain Mapping 6: 203–215, 1998.
Ordidge, R. J., Connelly, A. and Lohman, J. A. B., A general approach to selection of multiple cubic volume elements using the ISIS technique. J. Magn. Reson. 66: 283–294, 1986.
Petroff, O. A. C., Spencer, D. D., Alger, J. R. and Prichard, J. W., High-field proton magnetic resonance spectrosocpy of human cerbrum obtained during surgery for epilepsy. Neurology 39: 1197–1201, 1989.
Pettegrew, J. W., Keshavan, M. S., Panchalingam, K., Strychor, S., Kaplan, D. B., Tretta, M. G. and Allen, M., Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry 48: 563–568, 1991.
Pouwels, P. J. and Frahm, J., Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn. Reson. Med. 39: 53–60, 1998.
Prost, R. W., Mark, L., Mewissen, M. and Li, S. J., Detection of glutamate/glutamine resonances by 1H magnetic resonance spectroscopy at 0.5 tesla. Magn. Reson. Med. 37: 615–618, 1997.
Purcell, E. M., Torrey, H. C. and Pound, R. V., Resonance absorption by nuclear magnetic moments in a solid. Phys. Rev. 69: 37–38, 1946.
Rabi, I. I., Zacharias, J. R., Millman, S. and Kusch, P., A new method of measuring nuclear magnetic moment. Phys. Rev. 53: 318, 1938.
Radda, G. K., The use of NMR spectroscopy for the understanding of disease. Science 233: 640–645, 1986.
Raichle, M. E., Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc. Natl. Acad. Sci. USA 95: 765–772, 1998.
Rempp, K. A., Brix, G., Wenz, F., Becker, C. R., Guckel, F. and Lorenz, W. J., Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193: 637–641, 1994.
Renshaw, P. F. and Wicklund, S., In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol. Psychiatry 23:465–475, 1988.
Renshaw, P. F., Guimaraes, A. R., Fava, M., Rosenbaum, J. F., Pearlman, J. D., Flood, J. G., Puopolo, P. R., Clancy, K. and Gonzalez, R. G., Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. Am. J. Psychiatry 149: 1592–1594, 1992.
Renshaw, R F., Lafer, B., Babb, S. M., Fava, M., Stoll, A. L., Christensen, J. D., Moore, C. M., Yurgelun-Todd, D. A., Bonello, C. M., Pillay, S. S., Rothschild, A. J., Nierenberg, A. A., Rosenbaum, J. F. and Cohen, B. M., Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry 41: 837–843, 1997.
Runge, V. M., Kirsch, J. E., Wells, J. W., Dunworth, J. N., Hilaire, L. and Woolfolk, C. E., Repeat cerebral blood volume assessment with first-pass MR imaging. J. Magn. Reson. Imaging 4: 457–461, 1994.
Sadato, N., Ibanez, V., Campbell, G., Deiber, M. R, Le Bihan, D. and Hallett, M., Frequency-dependent changes of regional cerebral blood flow during finger movements: functional MRI compared to PET. J. Cereb. Blood Flow Metab. 17: 670–679, 1997.
Schulder, M., Maldjian, J. A., Liu, W. C., Mun, I. K. and Carmel, P. W., Functional MRI-guided surgery of intracranial tumors. Stereotactic Funct. Neurosurgery 68: 98–105, 1997.
Sholar, M. B., Mendelson, J. H., Mello, N. K., Siegel, A. J., Kaufman, M. J., Levin, J. M., Renshaw, P. F. and Cohen, B. M., Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men. J. Clin. Endocrinol. Metab. 83: 966–968, 1998.
Stehling, M. K., Turner, R. and Mansfield, P., Echo-planar imaging: magnetic resonance imaging in a fraction of a second. Science 254: 43–50, 1991.
Streeter, C. C., Ciraulo, D. A., Harris, G. J., Kaufman, M. J., Lewis, R. F., Knapp, C. M., Ciraulo, A. M., Maas, L. C., Ungeheuer, M., Szulewski, S. and Renshaw, P. F., Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism. Psychiatry Res. 82: 69–82, 1998.
Teicher, M. H., Anderson, C. M., Polcari, A., Glod, C. A., Maas, L. C. and Renshaw, P. F., Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder revealed using fMRI relaxometry. Nature Med. 6: 470–473, 2000.
Thomas, M. A., Ke, Y., Levitt, J., Caplan, R., Curran, J., Asarnow, R. and McCracken, J., Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia. J. Magn. Reson. Imaging 8: 841–846, 1998.
Tsai, G. and Coyle, J. T., N-Acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46: 531–569, 1995.
Turner, R., Jezzard, P., Wen, H., Kwong, K. K., Le Bihan, D., Zeffiro, T. and Balaban, R. S., Functional mapping of the human visual cortex at 4 and 1.5 tesla using deoxygenation contrast EPI. Magn. Reson. Med. 29: 277–279, 1993.
Warach, S., Chien, D., Li, W., Ronthal, M. and Edelman, R. R., Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 42: 1717–1723, 1992.
Warach, S., Levin, J. M., Schomer, D. L., Holman, B. L. and Edelman, R. R., Hyperperfusion of ictal seizure focus demonstrated by MR perfusion imaging. AJNR Am. J. Neuroradiol. 15: 965–968, 1994.
Warach, S., Dashe, J. F. and Edelman, R. R., Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J. Cereb. Blood Flow Metab. 16: 53–59, 1996.
Weisskoff, R. M., Chesler, D., Boxerman, J. L. and Rosen, B. R., Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn. Reson. Med. 29: 553–558, 1993.
Williamson, P., Pelz, D., Merskey, H., Morrison, S., Karlik, S., Drost, D., Carr, T. and Conolon, P., Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects. Am. J. Psychiatry 159: 549–551, 1992.
Xiong, J., Rao, S., Gao, J. H., Woldorff, M. and Fox, P. T., Evaluation of hemispheric dominance for language using functional MRI: a comparison with positron emission tomography. Human Brain Mapping 6: 42–58, 1998.
Yurgelun-Todd, D. A., English, C. D. and Cohen, B. M., Abnormal proton relaxation times in schizophrenia: an echo-planar study. Society of Magnetic Resonance, Third Scientific Meeting and Exhibition. Nice, France, p. 1239, 1995.
Zhang, M., Booze, R. M., Nicholls, M. A., Andersen, A. H., Welch, M. A., Strupp, B. J., Mactutus, C. F. and Avison, M. J., Cerebral response to cocaine and cocaine methiodide in the adult rat studied by fMRI. International Society for Magnetic Resonance in Medicine, Sixth Scientific Meeting and Exhibition. Sydney, Australia, p. 1580, 1998.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, New Jersey
About this chapter
Cite this chapter
Renshaw, P.F., Frederick, B.d., Maas, L.C. (2001). Fundamentals of Magnetic Resonance. In: Kaufman, M.J. (eds) Brain Imaging in Substance Abuse. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-021-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-021-6_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-180-6
Online ISBN: 978-1-59259-021-6
eBook Packages: Springer Book Archive